You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 6, March 27, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Bacterial Infections
 •Urinary Tract Disorders
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic

Current Antibiotic Therapy for Isolated Urinary Tract Infections in Women

Alexander J. Kallen, MD; H. Gilbert Welch, MD, MPH; Brenda E. Sirovich, MD, MS

Arch Intern Med. 2006;166:635-639.

Background  Sulfa antibiotics, such as a combination product of trimethoprim and sulfamethoxazole, have traditionally been the drugs of choice for urinary tract infections (UTIs) and remained the most common treatment as recently as a decade ago. However, increasing sulfa resistance among Escherichia coli may have led to changes in prescribing practices.

Methods  We used the 2000-2002 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey to obtain nationally representative data on antibiotics prescribed for women with isolated outpatient UTIs following visits to physicians' offices, hospital clinics, and emergency departments (n = 2638). Logistic regression was used to determine predictors of quinolone use.

Results  Quinolones were more commonly prescribed than sulfa antibiotics in each year evaluated. In the most recent year of data, quinolones were prescribed in 48% and sulfas in 33% of UTI visits (P<.04). Quinolones were significantly more likely to be prescribed to older patients and in visits occurring in the Northeast; however, no difference in quinolone prescribing was seen when evaluating insurance status, setting, race, ethnicity, health care provider type, and year. Approximately one third of the quinolones used were broader-spectrum agents.

Conclusions  Quinolones have surpassed sulfas as the most common class of antibiotic prescribed for isolated outpatient UTI in women. Few significant predictors of quinolone use exist, suggesting that the increase is not confined to a certain subset of patients. This pervasive growth in quinolone use raises concerns about increases in resistance to this important class of antibiotics.


Author Affiliations: VA Outcomes Group, VA Medical Center, White River Junction, Vt, and Dartmouth Medical School, Hanover, NH.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factors for Trimethoprim-Sulfamethoxazole Resistance in Patients with Acute Uncomplicated Cystitis
Colgan et al.
Antimicrob. Agents Chemother. 2008;52:846-851.
ABSTRACT | FULL TEXT  

Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women
Gupta et al.
Arch Intern Med 2007;167:2207-2212.
ABSTRACT | FULL TEXT  

Empiric Treatment of Uncomplicated Urinary Tract Infection with Fluoroquinolones in Older Women in Israel: Another Lost Treatment Option?
Kahan et al.
The Annals of Pharmacotherapy 2006;40:2223-2227.
ABSTRACT | FULL TEXT  

Treating Uncomplicated UTIs: Inappropriate Use of Quinolones?
JWatch General 2006;2006:3-3.
FULL TEXT  

Increased Fluoroquinolone Use for Outpatient UTIs
JWatch Infect. Diseases 2006;2006:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.